Polypharmacy and multiple sclerosis: A population-based study.

Anibal S Chertcoff Huah Shin NgFeng ZhuYinshan ZhaoHelen Tremlett

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)

More than one in four MS persons met criteria for polypharmacy. The odds of polypharmacy were higher for women, older persons, and those with more comorbidities, but lower SES.

Keyphrases

multiple sclerosis
adverse drug
mass spectrometry
polycystic ovary syndrome
white matter
physical activity
ms ms
tyrosine kinase
community dwelling
emergency department
middle aged
type diabetes
pregnant women
cervical cancer screening
breast cancer risk